Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy-Reference-Cited by-同舟云学术

Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy

Published:1987-06 Issue:6 Volume:82 Page:1109-1118
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Schwartz Ronald G.,McKenzie William B.,Alexander Jonathan,Sager Philip,D'Souza Anthony,Manatunga Amita,Schwartz Peter E.,Berger Harvey J.,Setaro John,Surkin Lee,Wackers Frans J.Th.,Zaret Barry L.

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. A clinicopathologic analysis of Adriamycin cardiotoxicity;Lefrak;Cancer,1973

2. Adriamycin (NSC 123127) cardiomyopathy;Lefrak;Cancer Chemother Rep,1975

3. Adriamycin (NSC 123127) cardiotoxicity: a clinicopathologic correlation;Cortes;Cancer Chemother Rep,1975

4. Adriamycin cardiomyopathy—risk factors;Minow;Cancer,1977

5. Congestive heart failure due to Adriamycin cardiotoxicity: its natural history in children;Goorin;Cancer,1981

Cited by 433 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection Using Doxorubicin: The Role of Dexrazoxane;Pharmaceutical Science;2024-07-10

2. The role of magnetic resonance imaging in cardio-oncology;MD-Onco;2024-06-14

3. Effect of variable left ventricular ejection fraction assessed by equilibrium radionuclide angiocardiography using different software packages on the diagnosis of cardiotoxicity in patients with cancer;Journal of Nuclear Cardiology;2024-01

4. Reliable left ventricular ejection fraction assessment: A fundamental need in cardio-oncology;Journal of Nuclear Cardiology;2024-01

5. Screening of Myocardial Cardiotoxicity Induced by Anticancer Chemotherapy and the Importance of Global Longitudinal Strain;World Journal of Cardiovascular Diseases;2024